Although TTR deposit reduction was not statistically significant across all tissues and doses examined, a clear trend emerged in which it appeared that intermediate gene silencing led to intermediate levels of TTR deposit reduction.
← all excerpts
Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis.
1
—
—